Leheny A. Rachel 4
4 · CalciMedica, Inc. · Filed Aug 27, 2024
Insider Transaction Report
Form 4
Leheny A. Rachel
DirectorCHIEF EXECUTIVE OFFICER10% Owner
Transactions
- Purchase
Common Stock
2024-08-27$4.19/sh+1,000$4,190→ 110,926 total
Holdings
- 356,989(indirect: By LLC)
Common Stock
- 316,109(indirect: By LLC)
Common Stock
- 1,000(indirect: By Spouse)
Common Stock
- 66,228(indirect: By LLC)
Common Stock
Footnotes (1)
- [F1]The weighted average purchase price for the transaction reported was $4.1898, and the range of prices were between $4.20 and $4.27. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.